Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Has results × Exercise Therapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Lymphoid 1

Conditions

Multiple Myeloma 1 Lymphoma 1

Interventions

Cyclophosphamide 513 Bevacizumab 458 Carboplatin 435 Paclitaxel 429 Cisplatin 383 pembrolizumab 355 Gemcitabine 350 Docetaxel 334 Rituximab 310 Radiotherapy 309 Dexamethasone 280 Doxorubicin 265 Nivolumab 239 Fluorouracil 227 Capecitabine 225 Etoposide 201 Prednisone 197 Oxaliplatin 196 Erlotinib Hydrochloride 194 Lenalidomide 187 Pemetrexed 186 Cytarabine 186 Trastuzumab 183 fludarabine phosphate 168 Cetuximab 168 Vincristine 167 Leucovorin 166 Bortezomib 163 Filgrastim 162 Irinotecan 148

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06063603 2025-09-18

ASCENT

Mayo Clinic

Phase NA Completed

51 enrolled 8 charts

LymphoidPlasma cell

Lymphoma, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡